Cargando…
Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis
OBJECTIVE: The value of antiangiogenic inhibitors for patients with recurrent ovarian cancer has not been completely affirmed. Therefore, we aimed to assess the effectiveness and toxicities of various antiangiogenic drugs for the treatment of recurrent ovarian cancer. METHODS: In this meta-analysis,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322854/ https://www.ncbi.nlm.nih.gov/pubmed/28255243 http://dx.doi.org/10.2147/OTT.S119879 |